Vitrolife AB Stock Nasdaq Stockholm
Stocks
SE0000816043
Medical Equipment, Supplies & Distribution
OTC Markets Traded
| Market Cap | 12.97B 1.38B 1.19B 1.1B 1.03B 1.93B 131B 1.96B 5.06B 63.83B 5.18B 5.07B 221B | P/E Ratio 2026 * |
26.4x | P/E Ratio 2027 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 13.3B 1.41B 1.22B 1.13B 1.05B 1.98B 134B 2.01B 5.18B 65.46B 5.31B 5.2B 227B | EV / Sales 2026 * |
3.79x | EV / Sales 2027 * | 3.38x |
| Free-Float |
54.39% | Yield 2026 * |
1.11% | Yield 2027 * | 0.95% |
Last Transcript: Vitrolife AB
| 1 day | -0.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Bronwyn O'Connor
CEO | Chief Executive Officer | 52 | 2023-07-31 |
Pär Ihrskog
DFI | Director of Finance/CFO | 55 | 2025-10-09 |
Nicklas Hansen
CIO | Chief Investment Officer | 39 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Pia Marions
BRD | Director/Board Member | 63 | 2013-04-18 |
| Chairman | 70 | 2023-07-31 | |
| Chairman | 55 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -6.68% | - | - | 1.38B | |
| +0.55% | +4.78% | +167.03% | +249.59% | 17.45B | |
| -1.74% | -7.00% | -43.82% | -25.79% | 9.25B | |
| +0.19% | +3.51% | +34.29% | +21.62% | 6.8B | |
| -0.17% | +8.98% | - | - | 5.08B | |
| -0.39% | -2.02% | -27.97% | -27.14% | 5.06B | |
| -2.92% | -6.89% | -28.74% | -31.75% | 4.08B | |
| -1.36% | -13.84% | +68.37% | +62.62% | 3.77B | |
| -0.72% | -7.09% | +176.91% | -50.20% | 3.66B | |
| +0.64% | +0.51% | -16.55% | -41.45% | 2.64B | |
| Average | -0.61% | -1.46% | +41.19% | +19.69% | 6.42B | |
| Weighted average by Cap. | -0.44% | -0.15% | +63.47% | +74.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.5B 373M 322M 297M 278M 521M 35.45B 529M 1.37B 17.25B 1.4B 1.37B 59.74B | 3.77B 402M 347M 320M 299M 561M 38.17B 569M 1.47B 18.58B 1.51B 1.48B 64.34B |
| Net income | 491M 52.27M 45.15M 41.6M 38.94M 72.98M 4.97B 74.11M 192M 2.42B 196M 192M 8.37B | 610M 64.88M 56.03M 51.64M 48.33M 90.58M 6.17B 91.98M 238M 3B 243M 238M 10.39B |
| Net Debt | 330M 35.07M 30.29M 27.91M 26.13M 48.97M 3.33B 49.73M 129M 1.62B 132M 129M 5.62B | -222M -23.6M -20.38M -18.78M -17.58M -32.95M -2.24B -33.46M -86.47M -1.09B -88.57M -86.68M -3.78B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
